Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
The American Journal of Gastroenterology
|
March 2, 2026
Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis
Anish Reddy, Adrielly Martins, Christopher L Bowlus, et al.
Transplantation Direct
|
May 20, 2026
Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality
Kelli C Kosako Yost, Megan B Ghai, Majd Aboona, et al.
Ophthalmology Science
|
October 27, 2025
Optic Nerve Head Changes over 15 Years-From the Atropine Treatment Long-Term Assessment Study
Leila Sara Eppenberger, Ezekiel Ze Ken Cheong, Joey Chung, et al.
Plos One
|
October 31, 2017
TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
Gloria H Y Lin, Vien Chai, Vivian Lee, et al.
Cancer Treatment and Research Communications
|
January 15, 2026
RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancer
Udit Nindra, Jun Hee Hong, Martin Hong, et al.
Scientific Reports
|
May 10, 2014
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
Bo Gao, Amanda Russell, Jonathan Beesley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2006
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer
Mark Wong, Rosemary L Balleine, Elaine Y L Blair, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2024
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study
Michael J Overman, Fabio Gelsomino, Massimo Aglietta, et al.
Breast (Edinburgh, Scotland)
|
November 8, 2020
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio
Clara Inkyung Lee, Siew Kee Low, Ricardo Maldonado, et al.
Frontiers in Immunology
|
March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy
Mithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
The American Journal of Gastroenterology
|
March 2, 2026
Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis
Anish Reddy, Adrielly Martins, Christopher L Bowlus, et al.
Transplantation Direct
|
May 20, 2026
Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality
Kelli C Kosako Yost, Megan B Ghai, Majd Aboona, et al.
Ophthalmology Science
|
October 27, 2025
Optic Nerve Head Changes over 15 Years-From the Atropine Treatment Long-Term Assessment Study
Leila Sara Eppenberger, Ezekiel Ze Ken Cheong, Joey Chung, et al.
Plos One
|
October 31, 2017
TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
Gloria H Y Lin, Vien Chai, Vivian Lee, et al.
Cancer Treatment and Research Communications
|
January 15, 2026
RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancer
Udit Nindra, Jun Hee Hong, Martin Hong, et al.
Scientific Reports
|
May 10, 2014
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
Bo Gao, Amanda Russell, Jonathan Beesley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2006
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer
Mark Wong, Rosemary L Balleine, Elaine Y L Blair, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2024
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study
Michael J Overman, Fabio Gelsomino, Massimo Aglietta, et al.
Breast (Edinburgh, Scotland)
|
November 8, 2020
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio
Clara Inkyung Lee, Siew Kee Low, Ricardo Maldonado, et al.
Frontiers in Immunology
|
March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy
Mithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Page
of 10